Bristol-Myers Squibb - 47 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol-Myers Squibb since 1972 adjusted for splits. The latest closing stock price for Bristol-Myers Squibb as of September 18, 2019 is 49.86.
  • The all-time high Bristol-Myers Squibb stock closing price was 77.94 on October 28, 1999.
  • The Bristol-Myers Squibb 52-week high stock price is 63.69, which is 27.7% above the current share price.
  • The Bristol-Myers Squibb 52-week low stock price is 42.48, which is 14.8% below the current share price.
  • The average Bristol-Myers Squibb stock price for the last 52 weeks is 49.54.
Bristol-Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 47.6616 52.4300 53.8000 42.7700 49.8600 -4.08%
2018 57.7859 61.3100 68.9800 48.7600 51.9800 -15.18%
2017 57.5613 59.4500 65.3500 46.8200 61.2800 4.86%
2016 63.1920 67.0300 76.7700 49.2300 58.4400 -15.05%
2015 64.5237 59.5100 70.7100 57.3000 68.7900 16.53%
2014 52.2117 52.2700 61.3000 46.5900 59.0300 11.06%
2013 43.8476 32.7100 53.8400 32.7100 53.1500 63.09%
2012 33.2952 35.0100 36.1500 30.8100 32.5900 -7.52%
2011 28.9302 26.5800 35.2900 24.9700 35.2400 33.08%
2010 25.6371 25.6300 27.9300 22.4400 26.4800 4.87%
2009 21.7191 23.8800 25.9600 17.5100 25.2500 8.60%
2008 21.6487 26.1300 27.0800 17.2600 23.2500 -12.33%
2007 28.8082 26.3800 32.1400 26.1000 26.5200 0.76%
2006 24.1178 23.2400 26.3200 20.2400 26.3200 14.53%
2005 24.2257 25.4300 26.4800 21.0300 22.9800 -10.30%
2004 25.1550 29.3500 30.6400 22.5000 25.6200 -10.42%
2003 25.2434 24.0300 28.8600 21.1300 28.6000 23.54%
2002 30.9320 50.8500 51.3000 20.5500 23.1500 -54.61%
2001 57.3467 71.5000 71.5000 49.0000 51.0000 -31.03%
2000 58.1863 64.4400 73.9400 43.5000 73.9400 15.19%
1999 68.1165 65.2000 77.9400 57.4400 64.1900 -4.05%
1998 54.3212 47.3150 66.9000 44.9050 66.9000 41.39%
1997 38.1206 26.7750 48.9050 26.7750 47.3150 73.63%
1996 23.0023 21.4075 28.9375 19.9375 27.2500 26.92%
1995 17.2268 14.7500 21.5325 14.5325 21.4700 48.38%
1994 13.9728 14.3750 15.1575 12.6575 14.4700 -0.64%
1993 14.6061 16.5950 16.5950 12.7825 14.5625 -13.70%
1992 17.9620 22.0625 22.1875 15.4375 16.8750 -23.51%
1991 19.8315 16.6575 22.0625 15.3450 22.0625 31.72%
1990 14.7655 14.2500 16.9375 12.7500 16.7500 19.64%
1989 12.4070 11.0950 14.2825 11.0000 14.0000 23.76%
1988 10.6511 10.8125 11.5000 9.6250 11.3125 8.70%
1987 11.9236 10.5463 13.7500 9.1250 10.4075 0.77%
1986 9.4609 8.2188 10.9838 7.5475 10.3275 24.71%
1985 7.3259 6.4063 8.4525 6.2188 8.2813 26.48%
1984 5.7989 5.3913 6.5625 5.2188 6.5475 23.98%
1983 4.8534 4.1875 5.9538 3.9375 5.2813 25.65%
1982 3.7147 3.2969 4.5781 3.1956 4.2031 26.58%
1981 3.2716 3.1875 3.6563 2.8831 3.3206 5.46%
1980 2.5446 2.2738 3.2113 1.9219 3.1488 36.16%
1979 2.1596 2.2263 2.3906 1.9531 2.3125 3.50%
1978 2.1048 2.0863 2.4844 1.7656 2.2344 6.30%
1977 2.0358 2.1250 2.2263 1.8047 2.1019 -2.00%
1976 2.2848 2.1641 2.5859 1.9334 2.1447 -0.35%
1975 1.9405 1.5975 2.3006 1.4725 2.1522 37.38%
1974 1.4518 1.4609 1.7541 0.9881 1.5666 8.11%
1973 1.9110 2.1406 2.2306 1.3750 1.4491 -32.80%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $81.363B $22.561B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $342.221B 14.90
Roche Holding AG (RHHBY) Switzerland $240.930B 0.00
Merck (MRK) United States $211.257B 17.37
Pfizer (PFE) United States $201.883B 11.89
Novartis AG (NVS) Switzerland $198.525B 17.07
Novo Nordisk (NVO) Denmark $120.697B 21.33
AstraZeneca (AZN) United Kingdom $113.163B 21.89
Sanofi (SNY) France $110.933B 13.63
Eli Lilly (LLY) United States $107.279B 20.02
AbbVie (ABBV) United States $105.859B 8.48
GlaxoSmithKline (GSK) United Kingdom $102.512B 12.88
Bayer (BAYRY) Germany $69.195B 10.08
H Lundbeck (HLUYY) Denmark $6.741B 9.73